Precision Nanomedicine to Target the Most Challenging Tumors

Summary

Eascra Biotech is leveraging International Space Station National Laboratory resources to advance next-generation chemotherapy and immunotherapy development for challenging tumors. This is a research partnership announcement with no clinical trial data or regulatory decisions included.